Macrolides and fluoroquinolones: insufficient intracellular activity
Empiric treatment principle
Clinical suspicion alone is sufficient to start treatment
Do not wait for PCR or serology confirmation
Treatment should be initiated in the ED or clinic
Diagnostic testing strategy
PCR as gold standard for acute illness
Whole blood PCR sensitivity > 95% during first 10 days of illness
Sensitivity decreases after doxycycline initiation
EDTA or heparin tube; transport on ice within 1 hour
Serology limitations
IFA IgG antibody titers frequently negative in first 7 to 10 days
Requires paired sera with fourfold rise in titer
Acute serology alone cannot be used to rule out diagnosis
IgG titer >= 1:128 supports diagnosis in later presentations
Treatment response as diagnostic confirmation
Defervescence within 24 to 48 hours strongly supports diagnosis
Used as clinical confirmation when PCR result pending
Patient Discharge Instructions
copy discharge instructions
Ehrlichiosis home care instructions
Medications
Take doxycycline exactly as prescribed; complete the full course
Do not stop early even if feeling better
Take with a full glass of water; avoid lying down for 30 minutes after each dose
Avoid dairy, antacids, iron, and calcium supplements within 2 hours of each dose
Activity and diet
Rest as needed; activity as tolerated
Drink plenty of fluids to stay well hydrated
Light diet initially if nausea is present
Sun exposure
Doxycycline increases sensitivity to sunlight
Use sunscreen and protective clothing outdoors
Return to emergency department immediately for
Warning signs requiring urgent care
Fever that is not improving after 48 hours of antibiotics
Confusion, unusual drowsiness, or difficulty waking
Neck stiffness or severe headache not relieved by pain medication
Shortness of breath or chest pain
Unusual bruising, bleeding, or petechiae (pinpoint red spots)
Inability to keep medications down due to vomiting
Any new rash or rapidly spreading skin changes
Weakness in arms or legs, or difficulty speaking
Follow-up plan
Clinic or doctor follow-up
Within 48 to 72 hours of leaving the emergency department
Repeat blood tests to confirm lab values are improving
Report any failure to improve to your doctor immediately
Disease reporting
Ehrlichiosis is a reportable disease; public health may contact you
Tick bite prevention
Preventing future tick exposure
Use DEET-containing repellents on exposed skin
Permethrin-treated clothing for outdoor activities
Daily full-body tick checks after outdoor exposure
Prompt tick removal with fine-tipped tweezers
Avoid high grass and leaf litter in tick-endemic areas during peak season
Check pets for ticks regularly; tick prevention for pets
References
Guidelines and key sources
Primary guidelines and references
CDC Tickborne Diseases of the United States Reference Manual (6th ed, 2022)
Comprehensive clinical and epidemiological data
Case fatality rates and demographic data
MMWR Recommendations and Reports: Diagnosis and Management of Tickborne Rickettsial Diseases (Biggs et al., 2016)
Diagnostic and treatment recommendations for ehrlichiosis and anaplasmosis
CDC Level guidance for empiric doxycycline treatment
Wilderness Medical Society Clinical Practice Guidelines for Tick-Borne Illness (Ho et al., 2021)
Prevention and management guidance
Doxycycline dosing recommendations including pediatric use
IDSA/ASM Guide to Microbiology Laboratory Utilization 2024 Update (Miller et al., 2024)
PCR and serological testing guidance
Specimen handling requirements
Key clinical studies
Evidence base
Gygax et al. PLoS NTD 2024: Systematic review of human monocytotropic ehrlichiosis
Comprehensive analysis of clinical features and outcomes
Iyamu et al. BMC Infectious Diseases 2024: Neurological manifestations of ehrlichiosis
Prevalence and clinical features of neuro-ehrlichiosis
Otrock et al. Blood Cells Mol Dis 2019: Ehrlichiosis in transplant patients and HLH
Outcomes data for immunocompromised populations
Cheng et al. Pediatrics 2016: ECMO use in HLH secondary to ehrlichiosis
Pediatric severe disease management
Dumler et al. Clin Infect Dis 2007: Ehrlichioses in humans epidemiology and treatment
Foundational clinical reference
Stone et al. JAMA 2004: Human monocytic ehrlichiosis
Classic clinical description and management framework
Coding reference
ICD-10 and classification
ICD-10 A77.40 Ehrlichiosis unspecified
Use when species not determined
ICD-10 A77.41 Ehrlichiosis chafeensis (E. chaffeensis)
Human monocytic ehrlichiosis (HME)
ICD-10 A77.49 Other ehrlichiosis
E. ewingii and E. muris eauclairensis
CDC Yellow Book 2025: Rickettsial Diseases (McCormick and Nicholson)
Travel medicine reference for tick-borne rickettsial diseases
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.